Marie Dahl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marie Dahl has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
- Jes Sanddal Lindholt
Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark
18 shared publications - Annette Høgh
Vascular Research Unit, Department of Vascular Surgery, Viborg Regional Hospital, Viborg, Denmark
8 shared publications - Lars Frost
Diagnostic Centre, University Clinic for Development of Innovative Patient Pathways, Silkeborg Regional Hospital, Silkeborg, Denmark
5 shared publications - Susanne Friis Søndergaard
Department of Health Aarhus University Aarhus Denmark
5 shared publications - Axel Cosmus Pyndt Diederichsen
Department of Cardiology, Odense University Hospital, Odense, Denmark
4 shared publications - Lars Melholt Rasmussen
Department of Clinical Biochemistry and Pharmacology (L.M.R.), Odense University Hospital, Denmark
4 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Wiley in Journal of Clinical Nursing
Loneliness as an Embodied and Existential Phenomenon in Later Life: A Qualitative Meta‐Synthesis of European Studies
Aim: To explore how loneliness is characterised among community‐dwelling older adults in European qualitative research. Design: A qualitative meta‐synthesis following Sandelowski and Barroso's interpretive framework. Methods: Qualitative studies published from 2015 onwards that explored loneliness among community‐dwelling adults aged 65 years or older in Europe were included. Data were extracted and synthesised using constant targeted comparison to identify similarities and differences across studies. A meta‐summary was followed by an interpretive synthesis to develop an integrated understanding. Each study was appraised for methodological quality and typology of findings. Data Sources: CINAHL and PubMed were searched in March 2025 and updated in January 2026. PsycINFO was added in January 2026, supplemented by reference and citation tracking. Results: Fourteen articles from seven countries were included. Two themes were generated: Loneliness as an embodied and enduring condition in later life describes how loneliness shifts from an emotional experience to one shaping identity, daily rhythms and coherence. The burden of silence illustrates how physical decline, reduced social access and stigma contribute to withdrawal, concealment and protective quietness that preserves dignity while deepening isolation. Together, the themes depict loneliness as an embodied and existential phenomenon shaping identity, everyday life and ageing. Conclusion: Loneliness in later life is an embodied and existential phenomenon that extends beyond social disconnection. Implications for the Profession and/or Patient Care: These findings can help nurses recognise loneliness beyond social isolation and respond with person‐centred care that supports dignity and meaningful everyday life. Impact: This review addresses limited understanding of how loneliness is lived in later life. Loneliness may become embodied, shape identity and everyday routines, and be concealed through silence. The findings may inform nurses caring for community‐dwelling older adults in European contexts. Reporting Method: Reported in accordance with ENTREQ guidelines. Patient or Public Contribution: There was no patient or public contribution. What Does This Paper Contribute to the Wider Global Clinical Community?: Loneliness in later life is an embodied and existential experience that extends beyond social isolation and influences how older adults experience everyday life. Nurses should recognise that loneliness may be communicated through silence, changing routines and altered identity rather than through direct disclosure. Understanding loneliness as a lived experience can support more person‐centred, relational nursing care that promotes dignity and meaningful engagement.
- 9 October 2026
- Published by Wiley in Journal of Clinical Nursing
Open AccessLoneliness as an Embodied and Existential Phenomenon in Later Life: A Qualitative Meta‐Synthesis of European Studies
Aim: To explore how loneliness is characterised among community‐dwelling older adults in European qualitative research. Design: A qualitative meta‐synthesis following Sandelowski and Barroso's interpretive framework. Methods: Qualitative studies published from 2015 onwards that explored loneliness among community‐dwelling adults aged 65 years or older in Europe were included. Data were extracted and synthesised using constant targeted comparison to identify similarities and differences across studies. A meta‐summary was followed by an interpretive synthesis to develop an integrated understanding. Each study was appraised for methodological quality and typology of findings. Data Sources: CINAHL and PubMed were searched in March 2025 and updated in January 2026. PsycINFO was added in January 2026, supplemented by reference and citation tracking. Results: Fourteen articles from seven countries were included. Two themes were generated: Loneliness as an embodied and enduring condition in later life describes how loneliness shifts from an emotional experience to one shaping identity, daily rhythms and coherence. The burden of silence illustrates how physical decline, reduced social access and stigma contribute to withdrawal, concealment and protective quietness that preserves dignity while deepening isolation. Together, the themes depict loneliness as an embodied and existential phenomenon shaping identity, everyday life and ageing. Conclusion: Loneliness in later life is an embodied and existential phenomenon that extends beyond social disconnection. Implications for the Profession and/or Patient Care: These findings can help nurses recognise loneliness beyond social isolation and respond with person‐centred care that supports dignity and meaningful everyday life. Impact: This review addresses limited understanding of how loneliness is lived in later life. Loneliness may become embodied, shape identity and everyday routines, and be concealed through silence. The findings may inform nurses caring for community‐dwelling older adults in European contexts. Reporting Method: Reported in accordance with ENTREQ guidelines. Patient or Public Contribution: There was no patient or public contribution. What Does This Paper Contribute to the Wider Global Clinical Community?: Loneliness in later life is an embodied and existential experience that extends beyond social isolation and influences how older adults experience everyday life. Nurses should recognise that loneliness may be communicated through silence, changing routines and altered identity rather than through direct disclosure. Understanding loneliness as a lived experience can support more person‐centred, relational nursing care that promotes dignity and meaningful engagement.
- Open Access
- 11 September 2026
- Published by Elsevier in Journal of Vascular Nursing
Self-reported outcome measures for assessing symptoms of anxiety and depression in patients with lower extremity artery disease: a scoping review
- 11 September 2026
- Published by Elsevier in Journal of Vascular Nursing
Open AccessSelf-reported outcome measures for assessing symptoms of anxiety and depression in patients with lower extremity artery disease: a scoping review
- Open Access
- 27 August 2026
- Published by Springer Nature in Pilot and Feasibility Studies
- Vol. 12 (1) , 138
Lessons from the Danish Vascular (DanVasc) pilot survey: patient-reported outcomes following lower extremity, carotid and aortic artery disease
Patient-reported outcomes are insufficiently studied across the three predominant vascular diseases: lower extremity artery disease (LEAD), symptomatic car
- 27 August 2026
- Published by Springer Nature in Pilot and Feasibility Studies
- Vol. 12 (1) , 138
Open AccessLessons from the Danish Vascular (DanVasc) pilot survey: patient-reported outcomes following lower extremity, carotid and aortic artery disease
Patient-reported outcomes are insufficiently studied across the three predominant vascular diseases: lower extremity artery disease (LEAD), symptomatic car
- Open Access
- 19 June 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Building bridges in diabetic foot ulcer care: a realist evaluation of the cross-sectoral use of telemedicine solutions
Over the past decade, the digitalization of health and telemedicine solutions has accelerated. Optimized digital infrastructure enables telemedicine as a complementary health care service, reducing organizational pressures and increasing accessibility. Tele medicine (TM) is well suited for chronic wound care, particularly diabetes-related foot ulcers, owing to its photo documentation and data exchange capabilities. This study aimed to explore health care professionals' (HCPs') cross-sectoral use of TM technology for the treatment and care of patients with diabetic foot ulcers (DFUs). The study used a realistic evaluation design. From 2023 to 2024, we conducted 68 h of participant observation of healthcare professionals in hospital and primary care during DFU treatment within a Danish cross-sectoral setting. The Standards for Reporting Qualitative Research (SRQR) were applied. We generated three key themes: (1) Time matters: navigating allocated and limited time in person-centred care and treatment. (2) Tech hurdles: adapting/aligning perceptions and mastering digital tools. (3) Building bridges: the power of relationships in sustaining telemedicine use. Our study led to a refined program theory allowing us to propose an answer to the problem of "what works, for whom, and under what circumstances": HCPs' cross-sectoral collaboration using the TM communication solution Pleje.net© enhances the treatment and care of patients with DFUs. This improvement is achieved in a cross-sectoral setting when care management addresses organizational challenges, such as managing time constraints, overcoming technological hurdles, and fostering strong relationships among HCPs. When robust relationships are present, the TM solution facilitates timely and coordinated care across different sectors, ultimately improving patient outcomes in a multidisciplinary setting. Findings are limited to a Danish cross-sectoral healthcare context and may not be directly transferable to other health systems.
- 19 June 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Open AccessBuilding bridges in diabetic foot ulcer care: a realist evaluation of the cross-sectoral use of telemedicine solutions
Over the past decade, the digitalization of health and telemedicine solutions has accelerated. Optimized digital infrastructure enables telemedicine as a complementary health care service, reducing organizational pressures and increasing accessibility. Tele medicine (TM) is well suited for chronic wound care, particularly diabetes-related foot ulcers, owing to its photo documentation and data exchange capabilities. This study aimed to explore health care professionals' (HCPs') cross-sectoral use of TM technology for the treatment and care of patients with diabetic foot ulcers (DFUs). The study used a realistic evaluation design. From 2023 to 2024, we conducted 68 h of participant observation of healthcare professionals in hospital and primary care during DFU treatment within a Danish cross-sectoral setting. The Standards for Reporting Qualitative Research (SRQR) were applied. We generated three key themes: (1) Time matters: navigating allocated and limited time in person-centred care and treatment. (2) Tech hurdles: adapting/aligning perceptions and mastering digital tools. (3) Building bridges: the power of relationships in sustaining telemedicine use. Our study led to a refined program theory allowing us to propose an answer to the problem of "what works, for whom, and under what circumstances": HCPs' cross-sectoral collaboration using the TM communication solution Pleje.net© enhances the treatment and care of patients with DFUs. This improvement is achieved in a cross-sectoral setting when care management addresses organizational challenges, such as managing time constraints, overcoming technological hurdles, and fostering strong relationships among HCPs. When robust relationships are present, the TM solution facilitates timely and coordinated care across different sectors, ultimately improving patient outcomes in a multidisciplinary setting. Findings are limited to a Danish cross-sectoral healthcare context and may not be directly transferable to other health systems.
- 28 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (39) , 5809-5821
Multi-modality non-invasive cardiovascular screening and sex-specific outcomes: the Viborg Screening Program
Background and Aims: Cardiovascular screening has been shown to reduce mortality in trials involving men. This study evaluated the effect of cardiovascular screening in both sexes, with all-cause mortality as the primary outcome. Methods: The Viborg Screening Program, a prospective, population-based study in Denmark, in which the intervention consisted of inviting all 67-year olds to screening for carotid plaque, lower extremity artery disease, abdominal aortic aneurysm, hypertension, cardiac arrhythmia/ischaemia, and diabetes mellitus. This cohort included invitees from the first 5 years (2014–2019). Controls were 67-year olds without screening access. Effects were evaluated using propensity score matching (1:3 ratio, nearest-neighbour matching) and analysed using Cox proportional hazards models under the intention-to-invite principle. Sex-stratified analyses of all-cause mortality were conducted post hoc. Results: Among 5505 invitees, three died before inclusion and 4602 participated (83.6%). Ninety individuals lacked registry information. After matching, 5412 invitees and 16 236 controls were included. During a median follow-up of 5.8 years, 372 (6.9%) invitees and 1444 (8.9%) controls died [hazard ratio (HR) 0.76, 95% confidence interval (CI) 0.68–0.85; P < .001]. The number needed to invite to save one life was 49. The HR for cardiovascular mortality was 0.76 (95% CI 0.56–1.03), for major adverse cardiovascular events 1.10 (95% CI 1.01–1.19), and for major adverse limb events 0.70 (95% CI 0.50–0.98). All-cause mortality HRs were 0.73 (95% CI 0.63–0.84) for men, 0.82 (95% CI 0.68–0.98) for women, 0.70 (95% CI 0.61–0.80) for those without prior cardiovascular disease (CVD), and 0.97 (95% CI 0.78–1.21) for those with prior CVD. Conclusions: Multi-modality non-invasive cardiovascular screening reduced 5-year all-cause mortality among 67-year olds, also when stratified by sex. Prioritizing individuals without known CVD may enhance population-level impact.
- 28 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (39) , 5809-5821
Multi-modality non-invasive cardiovascular screening and sex-specific outcomes: the Viborg Screening Program
Background and Aims: Cardiovascular screening has been shown to reduce mortality in trials involving men. This study evaluated the effect of cardiovascular screening in both sexes, with all-cause mortality as the primary outcome. Methods: The Viborg Screening Program, a prospective, population-based study in Denmark, in which the intervention consisted of inviting all 67-year olds to screening for carotid plaque, lower extremity artery disease, abdominal aortic aneurysm, hypertension, cardiac arrhythmia/ischaemia, and diabetes mellitus. This cohort included invitees from the first 5 years (2014–2019). Controls were 67-year olds without screening access. Effects were evaluated using propensity score matching (1:3 ratio, nearest-neighbour matching) and analysed using Cox proportional hazards models under the intention-to-invite principle. Sex-stratified analyses of all-cause mortality were conducted post hoc. Results: Among 5505 invitees, three died before inclusion and 4602 participated (83.6%). Ninety individuals lacked registry information. After matching, 5412 invitees and 16 236 controls were included. During a median follow-up of 5.8 years, 372 (6.9%) invitees and 1444 (8.9%) controls died [hazard ratio (HR) 0.76, 95% confidence interval (CI) 0.68–0.85; P < .001]. The number needed to invite to save one life was 49. The HR for cardiovascular mortality was 0.76 (95% CI 0.56–1.03), for major adverse cardiovascular events 1.10 (95% CI 1.01–1.19), and for major adverse limb events 0.70 (95% CI 0.50–0.98). All-cause mortality HRs were 0.73 (95% CI 0.63–0.84) for men, 0.82 (95% CI 0.68–0.98) for women, 0.70 (95% CI 0.61–0.80) for those without prior cardiovascular disease (CVD), and 0.97 (95% CI 0.78–1.21) for those with prior CVD. Conclusions: Multi-modality non-invasive cardiovascular screening reduced 5-year all-cause mortality among 67-year olds, also when stratified by sex. Prioritizing individuals without known CVD may enhance population-level impact.
- Open Access
Clinical relevance of screening for ECG abnormalities in 67-year-old Danes: a population-based cohort study from the Viborg Screening Programme (VISP)
Objectives: To describe the point prevalence of major ECG abnormalities, their coexistence with screen-detected cardiovascular disease (CVD) and the proportion requiring referral for cardiac work-up and interventions. Design: A population-based cohort study. Setting: Primary and secondary care settings in Denmark. Participants: Since 2014, all 67-year-old Danish men and women from Viborg municipality were invited to the ‘Viborg Screening Programme’ (VISP). Interventions: VISP includes screening for lower extremity artery disease (LEAD), carotid plaque (CP), abdominal aortic aneurysm (AAA), hypertension, diabetes mellitus and cardiac conditions. Primary outcome measures: A single resting 12-lead ECG was recorded and coded using the Minnesota criteria. Major ECG abnormalities were divided into rhythm and rate disorders, signs of myocardial damage and conduction disorders. Results: Over the first 5 years, 4612 (83.8% of those invited) were screened, with 4437 (96.4%) undergoing an ECG. We found major ECG abnormalities in 152 (3.4%), including 92 (2.1%) rhythm and rate disorders, 28 (0.6%) with signs of myocardial damage and 32 (0.7%) with conduction disorders. Fifty-nine (1.3%) had newly screen-detected ECG abnormalities, and 34 (0.8%) required intervention after cardiac consultation (32 medication adjustments and/or 11 advanced treatments). Participants with major ECG abnormalities had a higher frequency of coexisting CVD, including CP (46.4% vs 38.1%; p=0.040), LEAD (9.5% vs 5.3%; p=0.026) and AAA (2.7% vs 0.9%; p=0.032) and were also more common in men than in women (4.7% vs 2.2%; p<0.001). Adjusted OR showed significantly higher risk for screen-detected major ECG abnormalities in current smokers (aOR 2.07, 95% CI 1.05 to 4.09), but a lower risk in participants using lipid-lowering medication (aOR 0.39, 95% CI 0.19 to 0.80). Conclusion: This study provides a detailed overview of major ECG abnormalities in a population-based cardiovascular screening context. Although the yield of ECG screening was low, ECG may still add value as a simple and low-cost tool within multimodal programmes, enabling timely detection and treatment. Trial registration number: NCT03395509 .
Open AccessClinical relevance of screening for ECG abnormalities in 67-year-old Danes: a population-based cohort study from the Viborg Screening Programme (VISP)
Objectives: To describe the point prevalence of major ECG abnormalities, their coexistence with screen-detected cardiovascular disease (CVD) and the proportion requiring referral for cardiac work-up and interventions. Design: A population-based cohort study. Setting: Primary and secondary care settings in Denmark. Participants: Since 2014, all 67-year-old Danish men and women from Viborg municipality were invited to the ‘Viborg Screening Programme’ (VISP). Interventions: VISP includes screening for lower extremity artery disease (LEAD), carotid plaque (CP), abdominal aortic aneurysm (AAA), hypertension, diabetes mellitus and cardiac conditions. Primary outcome measures: A single resting 12-lead ECG was recorded and coded using the Minnesota criteria. Major ECG abnormalities were divided into rhythm and rate disorders, signs of myocardial damage and conduction disorders. Results: Over the first 5 years, 4612 (83.8% of those invited) were screened, with 4437 (96.4%) undergoing an ECG. We found major ECG abnormalities in 152 (3.4%), including 92 (2.1%) rhythm and rate disorders, 28 (0.6%) with signs of myocardial damage and 32 (0.7%) with conduction disorders. Fifty-nine (1.3%) had newly screen-detected ECG abnormalities, and 34 (0.8%) required intervention after cardiac consultation (32 medication adjustments and/or 11 advanced treatments). Participants with major ECG abnormalities had a higher frequency of coexisting CVD, including CP (46.4% vs 38.1%; p=0.040), LEAD (9.5% vs 5.3%; p=0.026) and AAA (2.7% vs 0.9%; p=0.032) and were also more common in men than in women (4.7% vs 2.2%; p<0.001). Adjusted OR showed significantly higher risk for screen-detected major ECG abnormalities in current smokers (aOR 2.07, 95% CI 1.05 to 4.09), but a lower risk in participants using lipid-lowering medication (aOR 0.39, 95% CI 0.19 to 0.80). Conclusion: This study provides a detailed overview of major ECG abnormalities in a population-based cardiovascular screening context. Although the yield of ECG screening was low, ECG may still add value as a simple and low-cost tool within multimodal programmes, enabling timely detection and treatment. Trial registration number: NCT03395509 .
- 1 November 2025
- Published by Hogrefe Publishing Group in Vasa
- Vol. 54 (6) , 421-428
“The medicine doesn’t interest me at all.” Beliefs, health behaviors, and medication adherence in peripheral arterial disease
Summary: Background: Non-adherence to guideline-directed best medical therapies is prevalent in people with lower extremity peripheral arterial disease (PAD), constituting a significant challenge to effective treatment. Underlying drivers for non-adherence remain poorly understood. This study explored patients’ health-related beliefs and behaviours regarding antithrombotic and lipid-lowering therapy to identify opportunities for improvement. Patients and methods: Using a qualitative design, we conducted semi-structured interviews with patients with symptomatic PAD based on a purposeful sampling strategy. Patients were recruited from four vascular surgery departments in Denmark between December 2022 and January 2024, excluding those with cognitive impairment or terminal illness. Data were analysed using framework analysis based on the six domains of the Health Belief Model (HBM): perceived susceptibility, severity, benefits, barriers, cues to action, and self-efficacy. Results: Sixteen patients participated (median age: 69 years, 38% women); 68.8% had intermittent claudication, 18.8% had chronic limb-threatening ischemia, and 12.5% had undergone major amputation. Seven patients were adherent, and nine were non-adherent to secondary preventive therapy. Patients expressed low perceived awareness of PAD severity and its cardiovascular implications. Their perception of PAD centred around leg pain and its impact on everyday life, limiting their understanding of the benefits of secondary preventive therapies. Patients lacked knowledge about treatment goals and did not link secondary preventive therapy with PAD. Adherence barriers included inadequate understanding of PAD’s chronic progressive nature, concerns about side-effects, prescription confusion, and financial constraints. Internal adherence triggers included fear of recurring pain, complications, and early death. External cues to action included a trusting patient-provider relationship and receiving comprehensive, understandable information. Conclusions: This study highlights the multifaceted challenges hindering adherence to antithrombotic and lipid-lowering therapies. Addressing the limited disease awareness and the expressed need for patient-centred communication delivered in a trusting patient-provider relationship could serve as starting point for future strategies to improve adherence.
- 1 November 2025
- Published by Hogrefe Publishing Group in Vasa
- Vol. 54 (6) , 421-428
“The medicine doesn’t interest me at all.” Beliefs, health behaviors, and medication adherence in peripheral arterial disease
Summary: Background: Non-adherence to guideline-directed best medical therapies is prevalent in people with lower extremity peripheral arterial disease (PAD), constituting a significant challenge to effective treatment. Underlying drivers for non-adherence remain poorly understood. This study explored patients’ health-related beliefs and behaviours regarding antithrombotic and lipid-lowering therapy to identify opportunities for improvement. Patients and methods: Using a qualitative design, we conducted semi-structured interviews with patients with symptomatic PAD based on a purposeful sampling strategy. Patients were recruited from four vascular surgery departments in Denmark between December 2022 and January 2024, excluding those with cognitive impairment or terminal illness. Data were analysed using framework analysis based on the six domains of the Health Belief Model (HBM): perceived susceptibility, severity, benefits, barriers, cues to action, and self-efficacy. Results: Sixteen patients participated (median age: 69 years, 38% women); 68.8% had intermittent claudication, 18.8% had chronic limb-threatening ischemia, and 12.5% had undergone major amputation. Seven patients were adherent, and nine were non-adherent to secondary preventive therapy. Patients expressed low perceived awareness of PAD severity and its cardiovascular implications. Their perception of PAD centred around leg pain and its impact on everyday life, limiting their understanding of the benefits of secondary preventive therapies. Patients lacked knowledge about treatment goals and did not link secondary preventive therapy with PAD. Adherence barriers included inadequate understanding of PAD’s chronic progressive nature, concerns about side-effects, prescription confusion, and financial constraints. Internal adherence triggers included fear of recurring pain, complications, and early death. External cues to action included a trusting patient-provider relationship and receiving comprehensive, understandable information. Conclusions: This study highlights the multifaceted challenges hindering adherence to antithrombotic and lipid-lowering therapies. Addressing the limited disease awareness and the expressed need for patient-centred communication delivered in a trusting patient-provider relationship could serve as starting point for future strategies to improve adherence.
- 12 August 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (6) , 384-396
Association of Statin Treatment and Dose With the Clinical Course of Small Abdominal Aortic Aneurysms in Men: A 5-Year Prospective Cohort Study From 2 Population-Based Screening Trials
BACKGROUND: Abdominal aortic aneurysms (AAA) present with high morbidity and mortality when they occasionally rupture. No medical therapy has successfully been proven to reduce AAA growth, though both metformin and statins have been identified as potential treatments in multiple meta-analysis. This study aimed to investigate a potential relationship between statin use and AAA growth rates and risk of undergoing repair, rupture, or death. METHODS: The study population included all men with screening-detected AAAs (30–55 mm) from the 2 large, population-based, randomized screening trials; the Viborg Vascular Screening trial (inclusion, 2008–2011) and the Danish Cardiovascular Screening trial (inclusion, 2014–2018). The clinical database was supplemented with data from the nationwide Danish Healthcare Registries, including prescription and outcome data. Statin exposure was quantified by defined daily doses (DDD). The primary outcome was AAA growth rate, whereas secondary outcomes included the need for repair and a composite of repair, rupture, and all-cause death. Growth rates were calculated using linear regression. To evaluate the risk of repair, patients were followed from inclusion until surgery, rupture, death, 5-year follow-up, or December 31, 2021. RESULTS: A total of 998 aneurysmal men (median age, 69.5 [interquartile range (IQR), 67–72] years; median AAA diameter, 35.4 [IQR, 32–41.2] mm) were included. Statin use was significantly associated with reduced AAA growth rate; an increase of 1 DDD statin per day was associated with an adjusted change in growth rate of −0.22 mm/year [95% CI, −0.39 to −0.06]; P =0.009). The 5-year adjusted hazard ratio for undergoing repair per doubling of statin dose presented a significantly reduced adjusted hazard ratio (HR) of 0.82 ([95% CI, 0.70–0.97]; P= 0.023), which was significant after 2.5 years. Statin use was associated with a significantly lower risk of the composite outcome (surgery, rupture, and death) in a dose-dependent manner, with an adjusted HR of 0.83 ([95% CI, 0.73–0.94]; P =0.003) per doubling of statin dose. Findings were robust in a variety of sensitivity analyses. CONCLUSIONS: High-dose statin use was associated with decreased AAA growth rates and lowered risk of undergoing repair, rupture, and death. This nonrandomized study suggests that patients with AAA could benefit from high-dose statin use, beyond only targeting associated risk factors.
- 12 August 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (6) , 384-396
Association of Statin Treatment and Dose With the Clinical Course of Small Abdominal Aortic Aneurysms in Men: A 5-Year Prospective Cohort Study From 2 Population-Based Screening Trials
BACKGROUND: Abdominal aortic aneurysms (AAA) present with high morbidity and mortality when they occasionally rupture. No medical therapy has successfully been proven to reduce AAA growth, though both metformin and statins have been identified as potential treatments in multiple meta-analysis. This study aimed to investigate a potential relationship between statin use and AAA growth rates and risk of undergoing repair, rupture, or death. METHODS: The study population included all men with screening-detected AAAs (30–55 mm) from the 2 large, population-based, randomized screening trials; the Viborg Vascular Screening trial (inclusion, 2008–2011) and the Danish Cardiovascular Screening trial (inclusion, 2014–2018). The clinical database was supplemented with data from the nationwide Danish Healthcare Registries, including prescription and outcome data. Statin exposure was quantified by defined daily doses (DDD). The primary outcome was AAA growth rate, whereas secondary outcomes included the need for repair and a composite of repair, rupture, and all-cause death. Growth rates were calculated using linear regression. To evaluate the risk of repair, patients were followed from inclusion until surgery, rupture, death, 5-year follow-up, or December 31, 2021. RESULTS: A total of 998 aneurysmal men (median age, 69.5 [interquartile range (IQR), 67–72] years; median AAA diameter, 35.4 [IQR, 32–41.2] mm) were included. Statin use was significantly associated with reduced AAA growth rate; an increase of 1 DDD statin per day was associated with an adjusted change in growth rate of −0.22 mm/year [95% CI, −0.39 to −0.06]; P =0.009). The 5-year adjusted hazard ratio for undergoing repair per doubling of statin dose presented a significantly reduced adjusted hazard ratio (HR) of 0.82 ([95% CI, 0.70–0.97]; P= 0.023), which was significant after 2.5 years. Statin use was associated with a significantly lower risk of the composite outcome (surgery, rupture, and death) in a dose-dependent manner, with an adjusted HR of 0.83 ([95% CI, 0.73–0.94]; P =0.003) per doubling of statin dose. Findings were robust in a variety of sensitivity analyses. CONCLUSIONS: High-dose statin use was associated with decreased AAA growth rates and lowered risk of undergoing repair, rupture, and death. This nonrandomized study suggests that patients with AAA could benefit from high-dose statin use, beyond only targeting associated risk factors.
- 16 May 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 82 (4) , 1412-1420.e3
Multicomponent strategy for optimized peri- and postoperative wound care after open revascularization for peripheral atherosclerosis
- 16 May 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 82 (4) , 1412-1420.e3
Multicomponent strategy for optimized peri- and postoperative wound care after open revascularization for peripheral atherosclerosis